Moderate to Severe Atopic Dermatitis Clinical Trial
Center for Dermatology Clinical Research is conducting a new clinical study evaluating potential options for moderate to severe atopic dermatitis patients.
Study Overview
Ages: 18 to 65 are eligible Compensation: Compensation for your time and travel is available and study-related medication/lab tests provided at no cost
Study Duration: 9 clinic visits over 6 months
Study Purpose: This study is evaluating the safety and efficacy of an investigational subcutaneous injection treatment for atopic dermatitis
Moderate to Severe Atopic Dermatitis Clinical Trial
Center for Dermatology Clinical Research is conducting a new clinical study evaluating potential options for moderate to severe atopic dermatitis patients.
Study Overview
Ages: 18 to 65 are eligible Compensation: Compensation for your time and travel is available and study-related medication/lab tests provided at no cost
Study Duration: 9 clinic visits over 6 months
Study Purpose: This study is evaluating the safety and efficacy of an investigational subcutaneous injection treatment for atopic dermatitis
Moderate to Severe Atopic Dermatitis Clinical Trial
Center for Dermatology Clinical Research is conducting a new clinical study evaluating potential options for moderate to severe atopic dermatitis patients.
Study Overview
Ages: 18 to 65 are eligible Compensation: Compensation for your time and travel is available and study-related medication/lab tests provided at no cost
Study Duration: 9 clinic visits over 6 months
Study Purpose: This study is evaluating the safety and efficacy of an investigational subcutaneous injection treatment for atopic dermatitis
Moderate to Severe Atopic Dermatitis Clinical Trial
Center for Dermatology Clinical Research is conducting a new clinical study evaluating potential options for moderate to severe atopic dermatitis patients.
Study Overview
Ages: 18 to 65 are eligible Compensation: Compensation for your time and travel is available and study-related medication/lab tests provided at no cost
Study Duration: 9 clinic visits over 6 months
Study Purpose: This study is evaluating the safety and efficacy of an investigational subcutaneous injection treatment for atopic dermatitis
Moderate to Severe Atopic Dermatitis Clinical Trial
Center for Dermatology Clinical Research is conducting a new clinical study evaluating potential options for moderate to severe atopic dermatitis patients.
Study Overview
Ages: 18 to 65 are eligible Compensation: Compensation for your time and travel is available and study-related medication/lab tests provided at no cost
Study Duration: 9 clinic visits over 6 months
Study Purpose: This study is evaluating the safety and efficacy of an investigational subcutaneous injection treatment for atopic dermatitis
Moderate to Severe Atopic Dermatitis Clinical Trial
Center for Dermatology Clinical Research is conducting a new clinical study evaluating potential options for moderate to severe atopic dermatitis patients.
Study Overview
Ages: 18 to 65 are eligible Compensation: Compensation for your time and travel is available and study-related medication/lab tests provided at no cost
Study Duration: 9 clinic visits over 6 months
Study Purpose: This study is evaluating the safety and efficacy of an investigational subcutaneous injection treatment for atopic dermatitis
Moderate to Severe Atopic Dermatitis Clinical Trial
Center for Dermatology Clinical Research is conducting a new clinical study evaluating potential options for moderate to severe atopic dermatitis patients.
Study Overview
Ages: 18 to 65 are eligible Compensation: Compensation for your time and travel is available and study-related medication/lab tests provided at no cost
Study Duration: 9 clinic visits over 6 months
Study Purpose: This study is evaluating the safety and efficacy of an investigational subcutaneous injection treatment for atopic dermatitis
Moderate to Severe Atopic Dermatitis Clinical Trial
Center for Dermatology Clinical Research is conducting a new clinical study evaluating potential options for moderate to severe atopic dermatitis patients.
Study Overview
Ages: 18 to 65 are eligible Compensation: Compensation for your time and travel is available and study-related medication/lab tests provided at no cost
Study Duration: 9 clinic visits over 6 months
Study Purpose: This study is evaluating the safety and efficacy of an investigational subcutaneous injection treatment for atopic dermatitis
Moderate to Severe Atopic Dermatitis Clinical Trial
Center for Dermatology Clinical Research is conducting a new clinical study evaluating potential options for moderate to severe atopic dermatitis patients.
Study Overview
Ages: 18 to 65 are eligible Compensation: Compensation for your time and travel is available and study-related medication/lab tests provided at no cost
Study Duration: 9 clinic visits over 6 months
Study Purpose: This study is evaluating the safety and efficacy of an investigational subcutaneous injection treatment for atopic dermatitis
Moderate to Severe Atopic Dermatitis Clinical Trial
Center for Dermatology Clinical Research is conducting a new clinical study evaluating potential options for moderate to severe atopic dermatitis patients.
Study Overview
Ages: 18 to 65 are eligible Compensation: Compensation for your time and travel is available and study-related medication/lab tests provided at no cost
Study Duration: 9 clinic visits over 6 months
Study Purpose: This study is evaluating the safety and efficacy of an investigational subcutaneous injection treatment for atopic dermatitis